Showing 5191-5200 of 19420 results for "".
Dermatology and CTCL: Recommendations
https://reachmd.com/series/dermwire-tv/dermatology-and-ctcl-recommendations/26798/Larisa J. Geskin, MD, Professor of Dermatology at Columbia University Medical Center, discusses "Time to Act: A Global Patient-Focused Consensus for Improving Care in Cutaneous T-Cell Lymphoma (CTCL)," a global consensus statement from Kyowa Kirin that recommends, among other things, that dermatologDoctored: The Disillusionment of an American Physician
https://reachmd.com/programs/book-club/doctored-the-disillusionment-of-an-american-physician/7194/Many physicians today feel that they are not in control of their careers, but are rather walking on an unstable tightrope to meet their occupational, familial, and personal needs. Provoked by this unsettling experience, practicing cardiologist and author Dr. Sandeep Jauhar has written an introspecti3 Years of Real-World Data for an AD Biologic
https://reachmd.com/programs/practical-dermatology-type-ii-inflammation-journal-club/3-years-of-real-world-data-for-an-ad-biologic/50769/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Chief Medical Editor Neal Bhatia, MD, FAAD, discuss Dr. Bhatia’s article “Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-WorlTailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
https://reachmd.com/programs/eye-on-ocular-health/tailored-treatment-in-retinal-disease-using-biomarkers-to-guide-anti-vegf-therapy/36258/Fixed anti-VEGF dosing schedules are giving way to biomarker-guided treatment strategies in retinal disease. Tune in to hear Dr. Jennifer Caudle speak with Dr. Michael Javaheri about the imaging, genetic, and molecular indicators—like OCT features, CFH and ARMS2 variants, and IL-6—that are transformDESTINY-Breast04 Findings: T-DXd and Quality of Life in HER2-Low Metastatic Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/destiny-breast04-findings-t-dxd-and-quality-of-life-in-her2-low-metastatic-breast-cancer/36437/New insights from DESTINY-Breast04 highlight how trastuzumab deruxtecan (T-DXd) not only extends survival but also delays symptom deterioration in HER2-low metastatic breast cancer. In this AudioAbstract, Dr. Mimi Maeusli discusses key takeaways from the outcomes analysis and what they mean forManaging Fatigue and Pruritus in Primary Biliary Cholangitis: A Stepwise Approach
https://reachmd.com/programs/gi-insights/managing-fatigue-and-pruritus-in-primary-biliary-cholangitis-a-stepwise-approach/29161/Here’s how we can improve the quality of life of patients dealing with the invisible symptoms of primary biliary cholangitis.Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
https://reachmd.com/programs/project-oncology/prostate-cancer-care-overcoming-challenges-in-delivering-germline-testing-to-veterans/17878/Here’s how we can improve informed decision-making for veterans with advanced prostate cancer who are thinking about doing germline testing.Post COVID-19 Psychological Distress: A Review of Risk Factors & Patient Burden
https://reachmd.com/programs/covid-19-frontlines/post-covid-19-psychological-distress-a-review-of-risk-factors-patient-burden/14207/New research on a patient’s psychological distress after being infected by COVID-19 may improve our approach to caring for long COVID patients. Find out how.Healthcare Cost Containment and Medical Liability Reform
https://reachmd.com/programs/heart-matters/healthcare-cost-containment-and-medical-liability-reform/5513/Defensive medicine and medical liability concerns create a symbiotic relationship that costs everyone in the medical system. Has healthcare reform legislation addressed the medical malpractice issue, and will it do enough to contain healthcare costs? Dr. Mark McClellan, director of the Engelberg CenTreatment Approaches for Psoriatic Arthritis
https://reachmd.com/programs/practical-dermatology-il-17-journal-club/treatment-approaches-for-psoriatic-arthritis/48809/Naeim T. Issa, MD, PhD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the Mediterranean Journal of Rheumatology article “Emerging Targets in Psoriatic Arthritis: Dual IL-17A/F and Selective TYK2 Inhibition in a Clinical Perspective.”